Wegener's granulomatosis presenting with ischaemic stroke;Udar niedokrwienny mózgu w przebiegu ziarniniakowatości Wegenera

Pneumonologia i Alergologia Polska

Volumn 76, Issue 3, 2008, Pages 180-185

  Wieteska, Maria ^a,e   Wawrzyńska, Liliana ^a   Wiatr, Elzbieta ^b   Chabowski, Mariusz ^c   Bestry, Iwona ^d   Kurzyna, Marcin ^a   Torbicki, Adam ^a  

^a Klinika Chorób Wewn trznych Klatki Piersiowej   (Poland)

^b III Klinika Chorób P uc w Warszawie

^c Klinika Torakochirurgii

^d Instytut Gruźlicy i Chorób Płuc ^*

^e INSTYTUT GRU LICY I CHORÓB P UC   (Poland)

Author keywords

Ischaemic stroke; Neurological event; Wegener's granulomatosis

Indexed keywords

CYCLOPHOSPHAMIDE; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LUNG DISEASE; PATHOLOGY; RADIOGRAPHY; STROKE; WEGENER GRANULOMATOSIS;

ADULT; CYCLOPHOSPHAMIDE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG DISEASES; PREDNISOLONE; STROKE; WEGENER GRANULOMATOSIS;

EID: 48249149895     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Hoffman G., Kerr G., Leavitt R. Wegener's granulomatosis, an analysis of 158 patients. Ann. Intern. Med. 1992; 116: 488-498.
2. Frankel S., Cosgrove G., Cha S. i wsp. Update in the diagnosis and management of pulmonary vasculitis. Chest 2006; 129: 452-465.
3. White E., Lynch J.P. Pharmacological therapy for Wegener's granulomatosis. Drugs 2006; 66: 1209-1228.
4. Schnabel A., Holl-Urlich K., Dalchhoff K. i wsp. Efficacy of transbronchial biopsy in pulmonary vasculitides. Eur. Respir. J. 1997; 10: 2738-2743.
5. Del Buono E., Flint E. Diagnostic usefulness of nasal biopsy in Wegener's granulomatosis. Hum. Pathol. 1991; 22: 107-110.
6. Leavitt R., Fauci A., Bloch D. i wsp. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Artritis Rheum. 1990; 33: 1101-1107.
7. Puszczewicz M. Przeciwciała przeciw cytoplazmie granulocytów obojȩtnochłonnych (ANCA). Reumatologia 2005; 43: 341-348.
8. Hoffman G., Specks U. Antineutrophil cytoplasmatic antibodies. Artritis Reum. 1998; 41: 1521-1537.
9. Wiatr E., Łabȩcka H., Płodziszewska M. i wsp. Przydatność oznaczania miana ANCA dla diagnostyki ziaminiakowatości Wegenera. Pneumonol. Alergol. Pol. 1999; 67: 294-301.
10. Drachman D. Neurological complication of Wegener's granulomatosis. Arch. Neurol. 1962; 8: 145-155.
11. Nishino H., Rubino F., DeRemee R., Swanson J. i wsp. Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann. Neurol. 1993; 33: 4-9.
12. Moore P., Cupps T. Neurological complications of vasculitis. Ann. Neurol. 1983; 14: 155-167.
13. Konate A., Le Falher G., Crozat-Glosrelon S. i wsp. Incidence and presentation of central neurological manifestations of Wegener's granulomatosis: a monocentric study of 14 cases. Rev. Mod. Intern. 2004; 25: 183-188.
14. Kashiyama T., Suzuki A., Mizuguchi K. Wegener's granulomatosis with multiple cranial nerve involvements as the initial clinical manifestations. Intern. Med. 1995; 34: 1110-1113.
15. George T., Cash J., Farver C. i wsp. Mediastinal mass and hilar adenopathy: rare thoracic manifestations of Wegener's granulomatous. Artitis Rheum. 1997; 40: 1992-1997.